Condensed Consolidated Balance Sheets (USD $)	Sep. 30, 2013	Dec. 31, 2012
Current Assets
Cash and cash equivalents	$ 8,253,591	$ 1,221,701
Prepaid expenses and other current assets	45,284
Total Current Assets	8,298,875	1,221,701
Equipment and furnishings, less accumulated depreciation of $427,615 and $422,965	31,829	29,829
Patents, net of amortization of $7,292,837 and $6,789,497, respectively	4,422,608	4,925,948
Other assets	27,000	27,000
Total Assets	12,780,312	6,204,478
Current Liabilities
Accounts payable - trade	202,464	243,435
Accrued compensation and payroll taxes	98,720
Accrued consulting expense	61,282	61,283
Other accrued expenses	180,001	206,706
Total Current Liabilities	542,467	511,424
Long-Term Liability
Warrant liability	3,514,622	1,299,570
Total Liabilities	4,057,089	1,810,994
Stockholders' Equity
Preferred stock; par value $.001 per share; 25,000,000 shares authorized including; 8% convertible preferred stock, 746,666 and 2,478,185 shares issued and outstanding, respectively, liquidation preference $0.75 (in aggregate $570,585 and $1,896,117, respectively); Series A 8% convertible preferred stock, 2,958,334 shares issued and outstanding in 2013, liquidation preference $0.75 (in aggregate $2,246,855)	3,705	2,478
Common stock; par value $.001 per share; 250,000,000 authorized; 139,974,331 and 118,427,925 shares issued and outstanding, respectively	139,974	118,428
Paid-in capital	138,032,870	122,625,654
Deficit accumulated during the development stage	(129,453,326)	(118,353,076)
Total Stockholders' Equity	8,723,223	4,393,484
Total Liabilities and Stockholders' Equity	$ 12,780,312	$ 6,204,478